MENINGIOMA, MALIGNANT
Clinical trials for MENINGIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new MENINGIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for MENINGIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for brain tumor patients: drug shows promise in slowing meningioma growth
Disease control Recruiting nowThis study tests whether the drug regorafenib can slow or stop the growth of recurrent meningioma, a type of brain tumor. About 104 adults whose tumor has grown despite prior treatment will receive regorafenib. The goal is to see if the drug extends the time before the tumor prog…
Matched conditions: MENINGIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 07, 2026 20:12 UTC
-
New radiation approach may improve tumor control for brain tumor patients
Disease control Recruiting nowThis study tests a new radiation technique called hypofractionated stereotactic radiosurgery for people with grade II or recurrent grade I meningiomas after surgery. The treatment delivers higher doses of radiation over fewer sessions to kill remaining tumor cells while reducing …
Matched conditions: MENINGIOMA, MALIGNANT
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 22, 2026 13:52 UTC